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Snake Venom Extracellular vesicles 
(SVEVs) reveal wide molecular and 
functional proteome diversity
Victor Corassolla Carregari1,2, Livia Rosa-Fernandes  2,3, Paulo Baldasso1, 
Sergio Paulo Bydlowski4, Sergio Marangoni1, Martin R. Larsen3 & Giuseppe Palmisano2
Proteins constitute almost 95% of snake venom’s dry weight and are produced and released by venom 
glands in a solubilized form during a snake bite. These proteins are responsible for inducing several 
pharmacological effects aiming to immobilize and initiate the pre-digestion of the prey. This study 
shows that proteins can be secreted and confined in snake venom extracellular vesicles (SVEVs) 
presenting a size distribution between 50 nm and 500 nm. SVEVs isolated from lyophilized venoms 
collected from four different species of snakes (Agkistrodon contortrix contortrix, Crotalus atrox, 
Crotalus viridis and Crotalus cerberus oreganus) were analyzed by mass spectrometry-based proteomic, 
which allowed the identification of proteins belonging to eight main functional protein classes such 
as SVMPs, serine proteinases, PLA2, LAAO, 5′nucleotidase, C-type lectin, CRISP and Disintegrin. 
Biochemical assays indicated that SVEVs are functionally active, showing high metalloproteinase 
and fibrinogenolytic activity besides being cytotoxic against HUVEC cells. Overall, this study 
comprehensively depicts the protein composition of SVEVs for the first time. In addition, the molecular 
function of some of the described proteins suggests a central role for SVEVs in the cytotoxicity of the 
snake venom and sheds new light in the envenomation process.
Snakes are an important group of vertebrates with more than 3000 species1, currently distributed among 24 fam-
ilies2. Snakes are of great human interest due to the existence of many dangerously venomous species which are 
responsible for tens of thousands of human deaths per year3. All the venomous species have a venom gland that 
synthesizes, stores and secretes a complex mixture of biological molecules including proteins. Toxins with hemor-
rhagic and myonecrotic activity are generally found in the venoms of the Viperidae family due to synergic action 
of proteolytic enzymes, such as metalloproteinases and serine proteinases4. Such venom components are formed 
in the venom gland as pre-pro-proteins containing a signal peptide that, once cleaved, produces a mature protein 
released in its soluble form5. After analysis of deduced amino acid sequences from cloned cDNAs of dipeptidyl 
peptidase IV (DPP IV) and aminopeptidase A (APA), it was noticed that DPP IV and APA are type II membrane 
proteins that have one transmembrane domain near the N-terminus. N-terminal amino acid sequence analysis 
of the purified DPP IV revealed that the N-terminus is not processed. This molecular feature raised questions 
regarding the mechanism of protein secretion into venom5–7, which opened up the possibility of alternative routes 
for snake venom proteins secretion.
This conventional form for venom protein secretion was challenged due to observation of venom proteins 
with N-terminal transmembrane domains5–7, which opened up the possibility of alternative routes for snake 
venom proteins secretion.
Produced by a variety of cell types, extracellular vesicles (EVs) are able to transfer lipids, nucleic acids and 
proteins to recipient cells. Depending on the size and the origin, EVs can be classified as microvesicles and 
exosomes8,9. Microvesicles are formed by outward budding and fission of the plasma membrane10–12, whereas 
exosomes are formed intracellularly by inward budding of endocytic compartments membrane, leading to 
vesicle-containing endosomes, called multivesicular bodies (MVBs)10. MVBs eventually fuse with the plasma 
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membrane, thus releasing their internal vesicles (i.e., exosomes) into the extracellular space10,11,13. EVs are 
involved in many biological processes such as cell to cell communication, apoptosis rescue and immunological 
responses8,14–16. Moreover, they have been described to be highly involved in several pathological conditions 
such as cancer17, neurological18,19, cardiovascular20 and infectious diseases21. EVs have been isolated from differ-
ent organisms from bacteria22 to humans23 and from different biofluids such as blood, saliva, semen and breast 
milk24–29 using various analytical methods30. The presence of vesicles in the luminal face of secretory cells of snake 
venom glands has been observed since 197331 and three seminal studies have shown the presence of EVs, called 
microvesicles or exosome-like particles, in snake venom5,32,33. Despite a morphological characterization of EVs 
in snake venom freshly collected, comprehensive studies on the biological content of these vesicles have never 
been conducted.
Here we use mass spectrometry-based proteomics strategies to assess the protein content in these vesicles 
and we show for the first time: 1) the isolation of SVEVs from lyophilized venom, 2) the characterization of their 
morphological features, 3) the composition of their protein cargo and 4) their biochemical and cellular activity. 
The SVEVs analyzed in this study were isolated from lyophilized venoms from Agkistrodon contortrix contortrix, 
Crotalus cerberus oreganus, Crotalus atrox and Crotalus viridis species. Overall, this study shed new lights on 
SVEVs protein cargo and their function and proposes them as additional important players in the envenomation 
process.
Results and Discussion
Isolation and characterization of secreted vesicles from snake venoms. The isolation and char-
acterization of morphological and molecular features of SVEVs were performed using a comprehensive exper-
imental strategy as reported in Supplementary Fig. 1. Size exclusion chromatography (SEC) is a largely applied 
approach to isolate and purify snake venom proteins. However, the composition of the unretained fraction from 
the SEC column has been ignored and poorly characterized due to the low absorbance in the classical UV range. 
Despite the low 280 nm absorbance in the SEC column flow-through, we collected this unretained fraction 
and compared it with the retained fraction from crude lyophilized venom from four different snake species: 
Agkistrodon contortrix contortrix (A.C.C), Crotalus cerberus oreganus (C.O),Crotalus atrox (C.A) and Crotalus 
viridis C.V) (Fig. 1a–d). In order to visualize the protein content of the unretained fraction, SDS-PAGE was 
performed and compared with the total venom for each species (Fig. 1a–d). Interestingly, the unretained frac-
tions showed bands with proteins in a wide MW range from 10 kDa to 200 kDa. The SDS-PAGE protein pattern 
was different between the unretained fraction and the whole venom, suggesting a concentration/enrichment of 
particular proteins in the non-retained fraction. These first evidences suggested the presence of larger proteins 
complexes or extracellular vesicles (EVs) in the lyophilized snake venom. The presence of protein complexes 
was excluded since the proteins were separated under reducing and denaturing conditions. On the other hand, 
secreted fluids are known to be rich in EVs, which can be released from different cells of the organism. The EVs 
have a double layered membrane that protects their protein cargo, thereby allowing them to be carried over dis-
tances13 and exchanged between EVs-producing and target cells14–16. Several methods have been used to isolate 
EVs, where ultracentrifugation (UC) and SEC are among the most applied ones34. Two manuscripts have shown 
EVs isolation from freshly extracted venom from Crotalus durissus terrificus and Gloydius blomhoffii blomhoffii 
using differential ultracentrifugation and SEC, respectively5,33, suggesting that, in this study, the unretained SEC 
fraction could also contain proteins encapsulated in EVs.
Furthermore, dynamic light scattering (DLS) and transmission Electronic Microscopy (TEM) were performed 
to validate the presence of EVs. In all venoms analyzed, DLS showed two populations of vesicles with 100 and 
500 nm diameter (Fig. 2). It should be noted that Carneiro et al.33 observed vesicles with 48 nm average size and 
also vesicles with more than 100 nm and less than 40 nm. Accordingly, Ogawa et al.5 observed vesicles from 30 
to 130 nm in size. Extracellular vesicles8,9 have been classified into apoptotic bodies (>1000 nm), microvesicles 
(100–1000 nm), and exosomes (30–100 nm) depending on their size. The different size of SVEVs could be due to 
the isolation method, ultracentrifugation or SEC, and especially the use of fresh or lyophilized venom. Indeed, in 
this study, lyophilized venom was used and this could explain the presence of larger particles (500 nm) that could 
have been formed during the lyophilization process35,36. EVs tends to aggregate, flocculate and degrade during 
freeze-drying34,35 (patent CN104488850A).
Furthermore, TEM was performed on vesicles isolated from the four venoms (Fig. 2). The SVEVs appeared 
to be structurally intact with a classical exosomal cup-shaped and a lipid bilayer membrane. The size measured 
using the TEM was in agreement with the DLS data, showing a diameter range from 50 nm to 200 nm (Fig. 2). 
However, no large particles (500 nm) were observed. In order to isolate SVEVs from the whole lyophilized venom, 
differential ultracentrifugation was performed as a complementary isolation method. On the isolated material, 
DLS and TEM analyses were performed, showing similar vesicle diameter and morphological characteristics to 
the ones obtained by size exclusion (Fig. 2 and Supplementary Fig. 2). Thus, the SVEVs isolated in this study using 
lyophilized venom share similar morphological characteristics to the ones obtained in the two previous reports.
Snake venom EVs were proposed to contain specific proteinases and prevent their activation inside the gland 
or direct their action through EVs-mediated delivery systems33. The presence of active dipeptidyl peptidase IV, 
aminopeptidase A and ecto-5′-nucleotidase was also demonstrated5. However, the full protein diversity and their 
biochemical and cellular functions have not yet been revealed. Therefore, a mass spectrometry-based proteomic 
strategy combined with bioinformatics and functional assays was applied to characterize the SVEVs proteome.
Proteomic characterization of the SVEVs. Inter and intra-species variation influences the venom com-
position and the protein concentration37–40. Proteomic analyses of venoms, termed “venomics”, have significantly 
expanded our knowledge and understanding of this biofluid41,42, allowing us to better understand the functional 
aspects of envenomation. In this study, a mass spectrometry-based bottom up proteomic workflow was applied to 
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identify the SVEVs proteome (Supplementary Fig 1). In particular, isolated SVEVs were lysed in urea and proteins 
digested using trypsin. Subsequently, tryptic peptides were analyzed using high resolution and accuracy mass 
spectrometry coupled to nanoflow liquid chromatography. Multiple database search engines such as Proteome 
Discoverer (SEQUEST), Peaks 7.1, MaxQuant (Andromeda), and the Trans Proteomic Pipeline (Comet) were 
utilized to assign peptide and protein identifications. A total of 706 non-redundant peptide sequences were iden-
tified in the four venoms using the four database search engines with 539, 378, 263 and 207 peptides identified 
using Peaks, Maxquant, TPP and Sequest, respectively (Supplementary Tables 1–20). Based on these peptide 
sequences, a total of 381 proteins were identified and grouped in eight functional classes including SVMPs, serine 
proteases, PLA2, LAAO, 5′nucleotidase, C-type lectin, CRISP and disintegrin (Figs 3a and 4a).
In particular, for the A.C.C., a total of 201 proteins were identified with 20 (10%) in common between the 
different search engines (Supplementary Fig. 3). For the C.O., a total of 85 proteins were identified with 6 (7.1%) 
proteins in common between the different search engines (Supplementary Fig. 3). A total of 89 proteins were 
identified in the C.A. venom vesicles with 3 (3.4%) proteins in common between the different search engines 
(Supplementary Fig. 3). For the C.V., a total of 169 proteins were identified with 9 (6.3%) in common between 
the different search engines (Supplementary Fig. 3). All proteins and peptides identified in each SVEV prepa-
ration are reported in Supplementary Tables 1–4 and 5–20, respectively. Taken together, these data showed low 
overlap among SVEVs proteins using different search engines (Fig. 3b). Snakes are able to survive in several 
habitats. Due to that, various environmental pressures could have promoted micro-evolutionary processes that 
caused modification of endogenous proteins43–45, which developed into different proteoforms from the same 
protein family. This protein and peptide complexity reflects the wide range of pharmacological effects pro-
duced by each venom component. Moreover, many snake species specialize on specific prey leading to selective 
Figure 1. Size Exclusion Chromatographic profile of the whole venom. Chromatographic profiles of the 
whole venom were obtained for each snake species using size molecular exclusion on Sephadex G75. Only the 
unretained fractions (indicated by grey line) were collected from each venom Agkistrodon contortrix contortrix 
(a), Crotalus cerberus oreganus (b), Cotalus atrox (c) and Crotalus viridis (d). The insert of each panel shows 
the SDS-PAGE separation of the proteins collected in the unretained fractions (lane 1) compared to the whole 
venom (lane 2). Molecular markers are reported on the side of the gel.
www.nature.com/scientificreports/
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pressures resulting in the evolution of advantageous venom phenotypes that may vary based on phylogenetic 
affinities37,38, geographic distribution46,47, snake age48 and diet49. Interestingly, a comparison between different 
search engines resulted in a modest overlap in the identified SVEVs proteins (Fig. 3b and Supplementary Fig. 3). 
Some proteins were identified with peptides shared between several proteoforms. Since each search engine 
uses a different strategy to assign the representative protein for each protein group, the overlap between the 
different search engines was modest. An example is the peptide RKDLLNR assigned to Group III snake venom 
metalloproteinase. In this case, MaxQuant and Peaks assigned it to different Uniprot IDs, E9KJY6 and E9KJZ0, 
respectively (Supplementary Tables 5–8). Another example is the peptide HDNAQLLTAIDLDR assigned to Zinc 
metalloproteinase-disintegrin-like VAP2A. In this case, TPP and MaxQuant assigned it to A4PBQ9 Uniprot ID 
and Sequest to C9E1R8 Uniprot ID. On the contrary, a comparison between non-redundant peptide sequences 
identified using different search engines showed high overlap for each venom (Supplementary Fig. 4a–d) and the 
Figure 2. Morphological analyses of the SVEVs. Transmission electron microscopy (TEM) images of vesicles 
isolates from lyophilized snake venom and size distribution of SVEVs analyzed with dynamic light scattering 
(DLS). (a) Agkistrodon contortrix contortrix (b) Crotalus cerberus oreganus (c) Cotalus atrox (d) Crotalus 
viridis.
www.nature.com/scientificreports/
5SCIeNtIFIC REpoRtS |  (2018) 8:12067  | DOI:10.1038/s41598-018-30578-4
four venoms combined (Supplementary Fig. 4e). Aiming to confirm the protein identifications obtained, tryptic 
peptides derived from SVEVs proteins were sequenced using EThcD fragmentation50. After database search, 
157 proteins were identified with high confidence and compared with all SVEVs proteins identified using HCD 
fragmentation. A complete overlap between the two datasets was observed providing further confidence to the 
identifications (Fig. 3c).
Figure 3. Different search tools provide distinct protein identification. Proteomic analysis of the proteins 
families for each snake venom species and an overview of all the proteins identifications and search tools 
analysis (SEQUEST, PEAKS, MaxQuant, TPP and Byonic for the EThcD). (a) Number of total SVEVs proteins 
identified by the each search engine. (b) Comparison of total SVEVs proteins identified by each database search 
engine. (c) Comparison of total SVEVs proteins identified by LC-MS/MS with two fragmentation techniques, 
HCD and EThcD. Byonic software was used to process EThcD data.
www.nature.com/scientificreports/
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Protein families in snake venom extracellular vesicles. Viperidae venoms contain proteins that inter-
fere with hemostasis and with the blood coagulation cascade, ultimately leading to immobilization, killing and 
pre-digestion of prey. Individual venom may contain well over 100 proteins and endogenous peptides includ-
ing various proteoforms51. These proteins can be classified into 10–15 protein families, such as the enzymatic 
L-amino acid oxidase (LAAOs)52, snake venom metalloproteinases (SVMPs)53, phospholipases A2 (PLA2) and 
serine proteinases54,55, as well as the non-enzymatic peptide myotoxins, C-type lectins, cysteine-rich secretory 
proteins (CRISPs) and disintegrins, among others37.
In this study, the most abundant protein families found in all the SVEVs were the metalloproteinases, followed 
by serine proteinases and phospholipase A2. Moreover, L-amino acid oxidase, cysteine-rich secretory protein 
(CRISP), 5′-nucleosidases, disintegrins and lectins were identified (Fig. 4a). The four venoms showed similar 
protein families distribution with the SVMPs, Serine Proteinases and Phospholipase A2, being present in higher 
number compared to LAAO, C-type lectins, CRISP and disintegrins (Fig. 4a). These results are in agreement 
with venomics data in the literature, which showed the presence of these same conserved protein families56,57. 
However, a different number of proteins belonging to the same protein family were identified in SVEVs isolated 
from the four venoms. Indeed, SVEVs isolated from A.C.C. and C.O. snake venoms contained a larger percentage 
of phospholipase A2 in comparison with the other venoms studied and with less proteins belonging to the serine 
proteinases family (Fig. 4a). A.C.C. venom has a different protein families profile compared to the Crotalus ven-
oms58 (Table 1). Indeed, the percentage of PLA2 protein family in the A.C.C. venom is 30% compared to less than 
10% in the C.O., C.A. and C.V. venoms (Table 1). A direct comparison between the percentages of protein families 
identified in the SVEVs and in the whole venom showed differences between the four venoms with enrichment of 
specific protein families in the SVEVs depending on the snake species (Table 1 and Fig. 4b). These data confirmed 
the various SVEVs protein profiles obtained by SDS-PAGE (Fig. 1). Therefore, SVEVs seem to contain the same 
protein families as the whole venom although with different representation (Table 1, Figs 1 and 4b), suggesting an 
important role of these vesicles in the envenomation process.
Interestingly, proteins related to hemostasis or blood coagulation, such as the bradykinin inhibitor pep-
tide and ohanin-like toxin (UniProtKB - P0CJ34 and Q27J48, respectively)59 were identified, (Supplementary 
Tables 1–4). One of the most studied biomolecules isolated from snake venoms are bradykinin and the 
Figure 4. Protein families identified by mass spectrometry-based proteomic analysis of SVEVs. (a) Snake 
venom extracellular vesicular content was analyzed by mass spectrometry-based proteomics revealing 
similar protein composition between all species. Snake venom metalloproteinase family, serine proteases and 
phospholipase A2 were among the most represented proteins. Each protein family is reported as percentage 
(Table 1). (b) A direct comparison between SVEVs and whole venom protein families is reported. The difference 
between the percentages of protein in SVEVs versus whole venom is reported for each family. Bar graph 
reporting in the x axis the protein families and y axis the difference between percentage of proteins in SVEVs 
minus percentage of proteins in whole venom for each protein family. The four venoms are reported as (a) 
A.C.C., (b) C.V., (c) C.O., (d) C.A.
www.nature.com/scientificreports/
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bradykinin-potentiating peptides. These biomolecules have helped in elucidating cardiovascular physiology60. 
In the literature, several reports on bradykinin-potentiating peptides have been published56,61,62. Recently, Sciani 
et al.63 identified novel cell penetrating peptides using the low molecular mass fraction of the Bothrops jara-
raca venom. In particular, proline-rich bradykinin potentiating peptide BPP-13a with a C-terminal Ile-Pro-Pro 
sequence was shown to penetrate human melanoma cell lines without cytotoxicity showing its ability as a cell 
penetrating peptide63. Proteomic analysis of SVEVs identified the bradykinin inhibitor peptide. Little is known 
about bradykinin inhibitor peptide and its role to antagonize the bradykinin function during vasodilatation64. In 
this study, the bradykinin inhibitor peptide (TPPAGPDVGPR, Uniprot P0CJ34|BKIP_CROAT) was identified 
in all SVEVs with high confidence suggesting a conserved role for this biomolecule in the biological function of 
the SVEVs. This peptide has four prolines with two located at the N-terminus suggesting a cell delivery function 
similar to the bradykinin potentiating peptides.
The identified proteins were classified according to their biological functions, cellular components and molec-
ular functions (Supplementary Fig. 5). The majority of proteins found in the proteomics analyses are present in 
the extracellular space (57–67%) and cell membrane (10%), indicating an enrichment of secreted proteins. The 
majority of the proteins are involved in metabolic processes, cell death, response to stimulus and defense response 
indicating specific roles of the SVEVs proteins. Interestingly, the percentage of SVEVs proteins associated to the 
different gene ontology categories was similar between the four venoms, indicating a conserved functional SVEVs 
proteome.
Proteinases represent an important class of proteins identified in SVEVs. Proteinases isolated from the snake 
venoms are generally classified by their active site into serine proteinases38 or metalloproteinases65. There are only 
few evidences for the presence of cysteine proteinases and aspartic proteinases in the venoms66,67. Some of them 
degrade mammalian tissue proteins in the site of bites in a nonspecific manner to immobilize the prey. However, 
a large proportion of them can cleave plasma proteins of the prey in a relatively specific manner to give potent 
-A.C.C. SVEVs % Whole Venoma %
PLA2 12 PLA2 31.5
SVMP 26 SVMP 32.5
SP 11 SP 14.3
LAAO 6 LAAO 4.4
CRISP 0.1 CRISP 3.7
C-type lectin 4 C-type lectin 2.4
Disintegrins 0.1 Disintegrins 1.5
-C.O. SVEVs % Whole Venomb %
PLA2 12 PLA2s 3.63
SVMP 33 SVMPs 31.9
SP 12 SP 21.2
LAAO 7 LAAO 7.3
CRISP 2 CRISP 3.03
C-type lectin 8 C-type lectins 0.78
Disintegrins 1 Disintegrins 1.67
-C.A. SVEVs % Whole Venomc %
PLA2 5 PLA2 7.3
SVMP 27 SVMP 49.7
SP 18 SP 19.8
LAAO 8 LAAO 8
CRISP 4 CRISP 3.7
C-type lectin N.D. C-type lectin 1.7
Disintegrins N.D. Disintegrins 6.2
-C.V. SVEVs % Whole Venomd %
PLA2 10 PLA2 9.2
SVMP 31 SVMP 11.2
SP 19 SP 26.8
LAAO 5 LAAO 2.2
CRISP 1 CRISP 3
C-type lectin 1 C-type lectin 2.6
Disintegrins 1 Disintegrin 0.1
Table 1. Comparison between protein families identified in the SVEVs and in the whole venoms117. The data 
presented for the whole venom have been collected from the literature. All comparisons were made for each 
corresponding specie as indicated: a40; b116; c42; d56. N.D. (not detected). The protein families reported are PLA2: 
phospholipase A2; SVMP: snake venom metalloproteinase; SP: serine proteases; LAAO: L-amino acid oxidase; 
CRISP: Cysteine-rich secretory protein; C-type Lectin and Disintegrins.
www.nature.com/scientificreports/
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effects, as either activators or inhibitors, on their hemostasis and thrombosis resulting in blood coagulation, 
fibrinolysis and platelet aggregation38,65,68,69. Serine proteinases are highly represented in the SVEVs proteome 
suggesting a possible function of these vesicles in the envenomation process.
Another important class of proteinases are snake venoms metalloproteinases (SVMP). These proteins are 
members of the Reprolysin subfamily of enzymes, which selectively cleave important peptide bonds of basement 
membrane (BM) components70,71, affecting the interactions with endothelial cells40,72. The ability of SVMPs to 
degrade BM components has been known for many years, and it has been hypothesized that hydrolysis of BM 
proteins is a key event in the onset of microvascular damage and hemorrhage73,74. SVMPs are classified into P-I, 
P-II and P-III classes, according to their domain organization75. When comparing the pattern of hydrolysis of 
BM components in vivo and in vitro between hemorrhagic and non-hemorrhagic P-I SVMPs from Bothrops sp. 
venoms, a striking difference was found regarding degradation of type IV collagen, as this BM component was 
hydrolyzed by the hemorrhagic toxin but not by the non-hemorrhagic SVMP76. Since type IV collagen plays a key 
role in the mechanical stability of BM and hence of the capillary vessel structure77,78, this observation is likely to 
have relevant functional implications regarding the mechanism of action of hemorrhagic SVMPs.
SVMPs are also synthesized as zymogens and their prodomain consists on average of 200 amino acids with a 
conserved sequence, similar to the MMPs and ADAMs prodomains, related to the cysteine-switch mechanism. 
This process controls the activation state of enzymes by blocking the catalytic site (inactivated state) and prote-
olytic processing of the prodomain (active state)79–81. As showed in previous studies82–84 the prodomains of the 
SVMPs are cleaved after maturation in the Golgi complex or as soon as they reach the lumen of the venom gland. 
Our proteomic data did not identify any peptide belonging to the prodomain site (Supplementary Fig. 6), suggest-
ing that these proteins could already be released activated in the SVEVs.
SVEVs show fibrinogenolytic activity. The cargo of the SVEVs include a high concentration of SVMPs 
and serine proteinases which affect both the hemostatic system and could present catalytic activity on fibrino-
gen85. Most of the venom MMPs, either hemorrhagic or non-hemorrhagic, are fibrin(ogen)olytic enzymes as well 
as the serine proteinases, cleaving preferentially the α-chain and slowly the β-chain of fibrinogen86. Some of the 
serine proteinases have both fibrogenolytic and fibrinolytic activities. When they have only the fibrinogenolytic 
activity, they are called ‘thrombin-like’ proteinases, presenting a fibrinogen clotting activity69,70. However, during 
the envenomation process their actions towards fibrinogen as well as other substrates is not exactly identical 
to those of thrombin. Instead of fibrin(ogen)olytic activity, several venom serine proteinases have the activity 
for releasing bradykinin from kininogen-like mammalian kallikrein (or kininogenase)52,87 and are also called 
‘kallikrein-like’ proteinases87. In addition, there have been few reports on the venom serine proteinases with a 
unique activity, such as the activation of factor V88, protein C89, plasminogen90, or platelets91.
To evaluate if SVEVs functionally resembles whole venom activity, proteolytic activity of A.C.C. SVEVs 
against fibrinogen was measured. The Aα and Bβ chains of fibrinogen were degraded in a time-dependent man-
ner (Fig. 5). The fibrinogenolytic activity was detected in the Aα chain at 1 h and Bβ chain at 6 h while the γ chain 
was unchanged (Fig. 5). This assay shows that purified SVEVs have fibrinogenolytic activity. It should be noted 
that Aα and Bβ chain degradation specificity is not absolute since there is substantial degradation of the alternate 
chain with increasing time and usually more related with hemorrhagic metalloproteinases86. This effect is quite 
important because it produces an abnormal fibrin clots composed for short polymers that are rapidly dispersed 
and no longer cross-linked by activated factor XIII, resulting in the disruption of the blood coagulation system of 
the preys and their immobilization4.
Figure 5. Snake venom EVs present fibrinogenolytic activity. Proteolysis of fibrinogen (2 mg/ml) was assessed 
by reducing SDS-gel electrophoresis (12%) after incubation with A.C.C. vesicles (15 µg) for different time points 
(0.25, 0.5, 1.0, 2.0, 6.0, 12 and 24 h). Fibrinogen alone was used as a control.
www.nature.com/scientificreports/
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SVEVs presents amidolytic, caseinolytic and esterase activities. In order to further characterize the 
proteolytic activity of SVEVs isolated from A.C.C venom, biochemical assays were performed using azocasein, 
BApNA and TAME (p-tosyl-L-arginine methyl ester) as substrates92,93. Before each proteolytic assay, the sam-
ple was submitted to probe tip sonication to release the SVEVs proteins. Every enzymatic assay performed was 
positive (Table 2), with high activity detected with azocasein substrate (566.53 ± 14.15 U/mg) when compared 
to others SVMPs94,95. The activity towards the BApNA substrate (0.17 ± 0,012 nmol/min) was lower compared 
to the Rhombeobin serine proteinase96. The lower activity found on BApNA substrate could be explained by the 
cleavage site specificity of the MMPs which require the presence of at least one hydrophobic amino acid, espe-
cially Leucine at the position P1′75,97,98. Another enzymatic assay was performed using this TAME substrate. The 
arginine in the TAME substrate have an ester bond with the chromophore while the BApNA have an amide bond 
between nitroaniline and arginine, therefore the TAME reveals esterolytic activity while the BApNA reveals ami-
dolytic activity67,99. We found a moderate activity towards the TAME substrate (Table 2), meaning that the serine 
proteinases found in the SVEVs have more affinity for the ester bond. This was also found in proteolytic studies of 
the contortrixobin (Thrombin-like toxin) activity over synthetic substrates100 (Table 2).
SVEVs and whole venom inhibits viability of HUVEC cells in a dose-dependent manner. To 
assess the cytotoxic activity of A.C.C. SVEVs obtained from SEC, as well as whole lyophilized venom, we eval-
uated the in vitro effect on the viability and proliferation of HUVEC endothelial cells by assessing their mito-
chondrial metabolic activity. Both SVEVs and whole venom inhibited viability of HUVEC cells in a dose 
dependent manner. Treatment with various concentrations of whole venom showed decreased cell viability in 
24 h (IC50 = 86.2 µg/mL), 48 h (IC50 = 58.6 µg/mL) and 72 h (IC50 = 63.2 µg/mL). Treatment of HUVEC cells 
with increasing concentrations of SVEVs proteins showed reduced cell viability at 24, 48 and 72 h, although 
the protein concentration required for obtaining 50% inhibition were higher than those observed for the whole 
venom (IC50 = 279.9, 202.1 and 202.2 µg/mL, respectively) (Fig. 6a–d). The observed difference between vesicle 
form and whole venom cytotoxicity is not surprising. An early study from Moran and Geren101 on A.C.C. venom 
fractions obtained by carboxymethyl cellulose chromatography described that none of the individual fractions 
presented more cytotoxicity than the whole venom.
To further characterize the effect of SVEVs obtained from SEC on HUVEC cells, changes in actin organization 
were investigated. After exposure to SVEVs for 24 and 48 h, HUVEC cells show disrupted fiber distribution, loss 
of intercellular contact and reduction in cell number per site (Fig. 6b–d), highlighting the cytotoxic potential 
of SVEVs associated with disruption of cell-cell and cell-matrix interactions in consequence of proteolysis of 
molecules on the cell surface and the extracellular matrix. SVEVs isolated from A.C.C venom are rich in proteins 
from the SVMPs P-II, which have been associated with endothelial cell cytotoxicity accompanied by morpho-
logical changes98,102. Vascular apoptosis-inducing proteins (VAPs) are toxins capable of triggering apoptosis of 
vascular endothelial cells associated with cell-detaching activity103. It should be noted that the observed cytotoxic 
effect could also be produced by PLA2s and LAAOs activities. Until now the proportion of encapsulated versus 
non-encapsulated venom proteins has not been fully elucidated. Ogawa and coworkers noticed that the majority 
of venom proteins were retained in the size exclusion chromatographic column indicating a low percentage of 
proteins encapsulated in snake venom vesicles5. Andréia Souza-Imberg et al. reported that the concentration 
of proteins in the microvesicles extract was 46.00 µg/mL of fresh venom, indicating a 0.1–0.2% of encapsulated 
versus total proteins104. In our study, we obtained 100 µg of proteins encapsulated in snake venom extracellular 
vesicles starting from 92 mg of total venom proteins loaded on the SEC column, indicating a 0.1% fraction. These 
results agree between them and indicate a low percentage of proteins encapsulated in the snake venom extracel-
lular vesicles. The biochemical and biological assays performed in our study confirmed that these vesicles are 
functional and more studies are needed to evaluate their specific activity.
Conclusions
In this study, SVEVs were isolated and characterized using a variety of methods including quantitative proteom-
ics. The presence and size of these vesicles was confirmed by DLS and TEM analysis, showing the possibility 
to isolate extracellular vesicles from lyophilized snake venoms. Proteomic analyses allowed us to identify 381 
proteins for all the species studied, belonging to defined functional GO categories such as cell death and defense 
response, suggesting an important role of these vesicles during the envenomation process. It was showed that 
the isolated extracellular vesicles are functional. Biochemical and functional assays showed the ability of the 
Activity Substrate SVEVs Other venom
Amidolytic BApNA 0.17 ± 0.012 (nmol/min) 1.06 ± 0.106 nmol/min (Lachesis muta rombeata/ Rhombeobin toxin)
96
0.58117 ± 0.0636 U/mg (Bothriopsis taeniata) Porto et al., 2007)118
Caseinolytic Azocasein 566.53 ± 14.5 (U/mg) or 0,821 nm (absorbance)
189,89 ± 25,59 U/mg (Bothrops marajoensis/BtaHF toxin)95
0,87 nm (absorbance)
(Agkistrodon contortrix contortrix)40
Esterase TAME 1109.66 ± 0.34 (U/mg) 282.0 ± 22.6 U/mg (Bothrops jararaca- Bj-PI2 toxin)
67
287 U/mg (Crotalus durissus cumanesis)119.
Table 2. Proteolytic activity of the SVEVs with BApNA (N-benzoyl-L-arginine ρ-nitroanilide), Azocasein 
and TAME (Nα-p-Tosyl-L-arginine methyl ester). Data are expressed as mean ± SD of three independent 
experiments. The proteolytic activity in SVEVs was compared to the whole venom or a specific toxin as reported 
in the literature.
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SVEVs proteins to hydrolyze synthetic substrates for metallo and serine proteinases and fibrinogenolytic activity. 
Cytotoxicity assays on HUVEC demonstrated the ability of SVEVs in reducing cell viability and changing actin 
organization.
Based on the molecular characterization and in vitro and in vivo functional evidences reported in this 
study, SVEVs could play an important role in the envenomation of the prey, causing hemostatic imbalance and 
endothelial degradation, reaching specific cells targets and increasing the efficiency of the prey paralysis. The data 
presented in this study represent a solid foundation to explore further the role of SVEVs in the envenomation 
process. Moreover, the proteomic analyses performed in this work could help in finding a possible marker for 
different species of snakes assisting and revealing new targets for the development of anti-venoms.
Methods
Size exclusion chromatography. SVEVs were isolated using size exclusion column (Superdex G75, GE 
Life Sciences) coupled to an ÄKTA chromatography system equipment (GE Healthcare life science). Fifty mil-
ligrams of the lyophilized venom was diluted in 1 mL of 1 M ammonium bicarbonate (AMBIC), centrifuged for 
5 minutes at 9000 rpm to remove contaminants such as epidermal cells and other cell debris. The supernatant was 
applied onto the column and eluted with a pump flow of 0.3 ml/min and 3 mL fractions were collected for each 
tube in an automatic fraction collector. The unretained fractions from the four venoms were lyophilized and ana-
lyzed by Dynamic Light Scattering (DLS) and Transmission Electron Microscopy (TEM). Two SVEVs isolation 
experiments were performed for each venom and further processed separately.
Characterization of vesicles. The unretained fractions from the four venoms, obtained by size exclusion 
chromatography, along with whole venom from Agkistrodon contortrix contortrix, Crotalus atrox, Crotalus viridis 
and Crotalus cerberus oreganus, were characterized by DLS and TEM. In order to concentrate the sample and 
remove salt interference for further analyses, each fraction was centrifuged at 20,000 × g for 2 h and the superna-
tant was further centrifuged at 100,000 × g for 2 h. All centrifugation steps were performed at 4 °C to avoid vesicle 
disruption. Both pellets were collected and vesicles were resuspended in 1 mL of PBS for DLS or formaldehyde 
fixed for TEM analysis as previously described105. Fixed pellets were placed on Formvar-coated copper grids, 
allowed to adsorb for 20 min, and processed for standard uranyl acetate staining. The grid was washed with 
PBS and allowed to semidry at room temperature before analysis by TEM (Jeol 1200 EXII). Average hydrody-
namic diameter of vesicles dispersed in PBS was determined at 25 °C by DLS using a Zetasizer Nano-ZS (Malvern 
Instruments).
Protein digestion and sample desalting. Snake Venom extracellular vesicles obtained from unre-
tained SEC fractions were dissolved in 8 M Urea, 50 mM ammonium bicarbonate (Ambic). Disulfide bonds were 
reduced by 10 mM DTT at 30 °C for 30 min and cysteines were alkylated by 40 mM iodoacetamide (IAA). Proteins 
were quantified using Qubit fluorometric detection kit (Thermo Fisher Scientific) and they were digested with 
Figure 6. A.C.C. whole venom or vesicles obtained by size exclusion chromatography inhibits viability of 
HUVEC cell line in a dose-dependent manner. (a) HUVEC cells were treated with several concentrations of 
A.C.C. whole lyophilized venom or SVEVs for 24 and 48 h and cell viability was assessed by MTT assay. Data 
are expressed as mean percentage of cells compared to control with standard errors of at least three independent 
experiments. (b–d) HCS analysis of fluorescein-phalloidin staining was used to observe changes in actin 
filaments organization (green) and nucleus (blue) of Huvec cells without treatment (b) and after treatment with 
A.C.C venom vesicles (240 µg/mL) for 24 h (c) and 48 h (d).
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porcine trypsin (1:25, w/w) overnight at room temperature. Peptides were desalted using reversed-phase micro-
columns packed with Oligo R3 (Applied Biosystem) as described previously106.
Analysis of Snake Venom Extracellular Vesicles by mass spectrometry. Samples were analysed 
by nanoflow liquid chromatography (Easy nLC, Thermo Fischer) coupled to a Q-Exactive HF (Thermo Fischer) 
mass spectrometers. Tryptic peptides were separated on a HPLC gradient 2–35% solvent B (A: 0.1% formic acid; 
B: 100% ACN, 0.1% formic acid) in 30 min at a flow of 250 nL/min. Mass spectrometric analysis was performed 
using a Q-Exactive HF mass spectrometer (Thermo Fisher Scientific) using a data-dependent acquisition mode. 
The most intense precursors selected from the FT MS1 full scan (resolution 35,000 FWHM @ m/z 200) were 
quadrupole-isolated and fragmented by HCD and detected in the Orbitrap mass analyser. The MS1 ion count target 
was set to 16 (AGC target) and precursor ions were acquired in the mass range of 400–1600 m/z in profile mode with 
a maximum IT 100 ms. MS2 ion count target was set to 1e5 and the max injection time was 50 ms. Top 12 precursor 
ions were selected with an isolation window of 2 m/z, fragmented at NCE 30 and detected in the Orbitrap at 17500 
resolution. The dynamic exclusion duration was set to 5 s with a 10 ppm tolerance around the selected precursor 
and its isotopes. Two biological replicates of all the venoms analysed. To further validate peptide identifications, the 
same samples were analysed on an Orbitrap Fusion Tribrid mass spectrometer (Thermo Fisher) and fragmented 
using EThcD fragmentation. MS1 spectra were recorded at resolution 120000 in the Orbitrap analyser with a scan 
range from 600–2000 m/z with quadrupole isolation. The automated gain control target was set to 5 × 105, with a 
max. injection time of 100 ms. The quadrupole was used for precursor isolation with an isolation window of 2 m/z 
with an intensity more than 30000. The monoisotopic precursor selection (MIPS) filter was activated. MS2 spectra 
were recorded at 30000 resolution in the Orbitrap analyzer. Precursor ions were fragmented using EThcD with ETD 
reaction time set to 75 ms and ETD supplemental collision energy 38.
Database search. Raw data were analyzed using four softwares with their associated search engines; 
Proteome Discoverer v2.1 (Thermo Scientific), MaxQuant107, Trans-Proteomic Pipeline (TPP) using the Petunia 
web interface108 and Peaks Studio 7.0 (Bioinformatics Solutions Inc.)109. Proteome Discoverer searches were 
performed using SequestHT while MaxQuant uses the embedded Andromeda search engine against the snake 
Uniprot110 protein database (41699 sequences, updated to January 2016) with the addition of 247 protein com-
mon contaminants. The following parameters were used: precursor mass tolerance 10 ppm, MS/MS mass tol-
erance 0.05 Da. Trypsin was selected as cleavage enzyme with strict cleavage specificity at C-terminal to K or R 
required. Up to two missed cleavages per peptide were allowed. Carbamidomethyl cysteine (+57.02 Da) was set 
as fixed modification. The variables modifications were methionine oxidation (+15.99 Da) and deamidation of 
asparagine and glutamine (+0.984 Da). Shared peptide sequences were grouped as grouped accessions proteins. 
Proteome Discoverer False Discovery Rates (FDR) at peptide spectrum matching (PSMs) level was calculated 
using the Percolator algorithm with q value equal or less than 0.01. Protein FDR was kept at less than 1% in both 
search engines. Relative protein expression was calculated using the Precursor Ion node in Proteome Discoverer 
and the LFQ with “match between runs” with a match time window of 0.7 min and an alignment time window of 
20 min using MaxQuant107. TPP database search was performing after converting the raw data files into mzXML 
format using msconvert. Then, the mzXML files were searched using COMET111. The snake Uniprot protein data-
base was used as described before. For COMET searches, the precursor ions mass error was set to ±10 ppm and 
0.05 Da MS/MS accuracy. Fixed and variable modifications were set as described before. Peptides and proteins 
were filtered using the PeptideProphet and ProteinProphet with less than 1% probability.
The raw data were also searched using PEAKS 7.0 (Bioinformatics Solutions Inc.) against the snake venom 
Uniprot110 protein database and filtered at a 1% false discovery rate at protein level. Fixed and variable modifica-
tions were set as previously described by M oxidation, NQ deamidation were searched for with a precursor ion 
tolerance of 10 ppm and a fragment ion tolerance of 0.05 Da. EThcD spectra were searched using the Byonic soft-
ware v.2.6.46 (http://www.proteinmetrics.com/Protein Metrics Inc.). Searches were performed with the following 
fixed modifications: precursor mass tolerance of 10 ppm, product ion mass tolerance of 0.05 Da, carbamidometh-
ylation Cys, and fully trypsin specific cleavage with a maximum of two missed cleavages. Variable modifications 
were set as before. Proteins were filtered with a FDR less than 1%. The mass spectrometric and database search 
features for each peptide sequence are reported in Supplementary Tables 5–20112.
Bioinformatic analysis. Proteins and peptides identified were further analysed using Protein Center soft-
ware (Thermo Fisher). Cellular components, biological functions and molecular functions gene ontologies were 
assigned for each snake species. All the proteins identified in the proteomic analyses were compared in different 
groups regarding the data base search tool used for the analysis using Venny 2.1113.
Fibrinogenolytic activity. Proteolytic activity upon fibrinogen was measured as described by Rodrigues et al.71 
with some modifications. Briefly, 900 µl of Fibrinogen solution (2 mg/ml) in 10 mM Tris-HCl (pH 7.8) were mixed 
with 20 µl of the sample in the same buffer at 37 °C for different time intervals: 15 min, 30 min, 1, 3 6, 12 and 24 h. 
Reaction was stopped with 900 µl of a solution containing 10% (v/v) glycerol, 10% (v/v) b-mercaptoethanol, 2% 
(v/v) SDS, and 0.05% (w/v) bromophenol blue and incubated for 24 hours. Fibrinogen hydrolysis was demon-
strated by SDS-PAGE using 12% polyacrylamide gels.
SDS-PAGE. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out on 
purified vesicles and in the total venom according to Laemmli114. The molecular mass markers used were Full 
Range Rainbow RPN 800 (Amersham ECL Rainbow Molecular Weight Markers- GE).
Amidolytic Activity and Determination of Kinetic Parameters. Amidolytic activity was meas-
ured using the synthetic substrate N-benzoyl-L-arginine ρ-nitroanilide (BAρNA) modified for 96-well plates. 
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The standard assay mixture contained 50 µL of buffer (10 mM Tris-HCl, pH 8.0, 10 mM CaCl2, and 100 mM 
NaCl), 200 µL of substrate solution (1 mM), 10 µL of water, and 10 µL of the released proteins from the vesicles 
after probe tip sonication in a final volume of 270 µL. The reaction was carried out in a VERSAMAX microplate 
reader (Molecular Devices Corporation, Sunnyvale, CA, USA) for 30 min at 37 °C, reading the absorbance at 
410 nm. The results were expressed as the initial velocity of the reaction (v0) calculated based on the amount of 
ρ-nitroaniline released92. The experiments were performed in triplicate.
Caseinolytic activity. Caseinolytic activity was determined colorimetrically over the substrate azocasein, 
following the method propose by Wang & Huang102. A total of 90 µl of the azocasein solution (5 mg/ml) diluted in 
Tris-HCl pH 8.0, and mixed with 10 µL of the proteins present inside of the vesicles and incubated for 90 minutes 
at the temperature of 37 °C. The reaction was stopped by trichloroacetic acid 5% (v/v), after the samples were sub-
mitted to 4 min centrifugation 4565 × g. A total of 150 µl of the supernatant was mixed in 150 µl NaOH (0, 5 M) 
and proteolytic activity was monitored by determination of azo-peptides produced by proteinase catalytic activity 
on azocasein an absorbance of 440 nm using a VersaMax microplate reader (Molecular Devices Corporation, 
Sunnyvale, CA). Proteolytic activity unit was defined as the enzyme quantity (mg), which hydrolyze 1 μg per min 
of azocasein at pH 8.0 and 37 °C115. The experiments were performed in triplicate.
Esterase activity. Esterase activity was assayed using Nα-p-tosyl-L-arginine ester (TAME)116. The reaction 
mixture consisted of 1.5 ml of substrate (1 mM TAME in 0.1 M Tris–HCl, pH 7.8), 1.4 ml of 0.1 M Tris–HCl, pH 
7.8, and 0.1 ml of sample. The mixture was incubated for 10 min at 25 °C after which the absorbance was meas-
ured at 253 nm. One unit of activity was defined as an absorbance increase of 0.001/min. The experiments were 
performed in triplicate.
Cell culture and experimental conditions. HUVEC cells were maintained in DMEM (Sigma-Aldrich) with 
10% (v/v) FBS, 100 U/ml penicillin-streptomycin, 3.7 g/L NaHCO3 at 37 °C with 5% CO2. Stock solutions of whole 
venom and samples obtained from size exclusion chromatography were prepared in DMEM or PBS prior to use.
Cell viability assays. Cell viability was determined using MTT colorimetric method. HUVEC cells were 
seeded at 96 well plates at a concentration of 0.5 × 104 cells and kept in culture conditions for at least 16 h before 
incubation with whole venom and samples obtained from size exclusion chromatography for 24, 48 and 72 h. 
After the designated time points, 1.2 mM MTT reagent (Sigma-Aldrich) was added, followed by DMSO 50% (v/v) 
after 4 h at 37 °C with 5% CO2. The experiment was performed using six replicates for each concentration and was 
repeated three times. The amount of formazan was determined by measuring the absorbance at 570 nm refereed 
to 630 nm wavelength. For IC50 calculations, survival data were evaluated by variable slope curve-fitting with 
GraphPad Prism Software (GradPad Software, CA).
Changes in F-actin organization. In order to investigate the effects of exposure to vesicles obtained from 
size exclusion chromatography on the actin cytoskeleton, Alexa Fluor 488® Phalloidin (Molecular Probes®) was 
used as a fluorescent dye according to manufactures instructions. Briefly, after 24 and 48 h treatment, cells were 
fixed in 4% paraformaldehyde, followed by permeabilization with 0.1% Triton X-100 and stained with 3 U/mL 
Alexa Fluor 488® Phalloidin for 30 min as cell nuclei were counterstained with Hoechst 33342 (Molecular 
Probes®). Experiments were evaluated with a fluorescence microscope ImageXpress Micro High Content System 
(Molecular Devices). Nine sites from each experiment were analyzed in triplicate using MetaXpress software 
(Molecular Devices).
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